Trial · NCT02129764
Prednisone for Heart Failure Patients With Hyperuricemia
NCT02129764, Phase 2, Phase 3, Completed, Hebei Medical University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Prednisone for Heart Failure Patients With Hyperuricemia. Trials, record NCT02129764. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02129764
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Prednisone for Heart Failure Patients With Hyperuricemia
- NCT number
- NCT02129764
- Status
- Completed
- Phases
- Phase 2, Phase 3
- Enrollment
- 205 participants, actual
- Lead sponsor
- Hebei Medical University
- Conditions
- Heart Failure, Hyperuricemia
- Interventions
- Prednisone, Allopurinol
- First posted
- 2014-05-02
- Last updated
- 2018-10-16
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in serum creatinine levels | 2 weeks | Change from baseline in serum creatinine levels at the end of study, i.e. 2 weeks |
| Secondary | Change from baseline in uric acid levels | 2 weeks | Change from baseline in uric acid levels at the end of study, i.e. 2 weeks |
| Secondary | Change from baseline in Cystatin C | 2 weeks | Change from baseline in cystatin c at the end of study, i.e. 2 weeks. |
| Secondary | the levels of tumor necrosis factor (TNF) alfa,IL-6 in the circulation, high-sensitivity C-reactive Protein (hs-CRP) | 2 weeks | Change of plasma TNF-alfa, IL-6, and hs-CRP levels at the end of study, i.e. 2 weeks (expressed as percentage of baseline) |
| Secondary | The levels of angiotensin II and aldosterone in the circulation. | 2 weeks | Change of plasma angiotensin II and aldosterone at end of week-1 (i.e. on day 7) and at the end of week-2 (i.e. on day 14), the values were expressed as percentage of baseline) |
| Secondary | Daily urine output | 2 weeks | 24-hour urine output at week-1 (i.e. on day 7) and at week-2 (i.e. on day 14) |
| Secondary | New York Heart Association (NYHA) functional class | 2 weeks | Change of NHHA functional class at the end of study |
| Secondary | 24h urinary sodium excretion | 2 weeks | 24-hour urinary sodium excretion at week-1 (i.e. on day 7) and at week-2 (i.e. on day 14) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02129764
GET https://conductscience.org/api/trials/v1/NCT02129764/registered